JPWO2020205605A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020205605A5 JPWO2020205605A5 JP2021557938A JP2021557938A JPWO2020205605A5 JP WO2020205605 A5 JPWO2020205605 A5 JP WO2020205605A5 JP 2021557938 A JP2021557938 A JP 2021557938A JP 2021557938 A JP2021557938 A JP 2021557938A JP WO2020205605 A5 JPWO2020205605 A5 JP WO2020205605A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- independently
- dsrna
- rna
- complementary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962826589P | 2019-03-29 | 2019-03-29 | |
US62/826,589 | 2019-03-29 | ||
US201962864789P | 2019-06-21 | 2019-06-21 | |
US62/864,789 | 2019-06-21 | ||
US201962910842P | 2019-10-04 | 2019-10-04 | |
US62/910,842 | 2019-10-04 | ||
PCT/US2020/025432 WO2020205605A2 (en) | 2019-03-29 | 2020-03-27 | OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022528487A JP2022528487A (ja) | 2022-06-13 |
JPWO2020205605A5 true JPWO2020205605A5 (ru) | 2023-04-03 |
Family
ID=72667058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021557938A Pending JP2022528487A (ja) | 2019-03-29 | 2020-03-27 | C9orf72のオリゴヌクレオチドベースの調節 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20200385737A1 (ru) |
EP (1) | EP3946374A4 (ru) |
JP (1) | JP2022528487A (ru) |
AU (1) | AU2020252020A1 (ru) |
CA (1) | CA3133784A1 (ru) |
WO (1) | WO2020205605A2 (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4017504A4 (en) * | 2019-08-23 | 2024-01-24 | Univ Massachusetts | O-METHYL-RICH FULLY STABILIZED OLIGONUCLEOTIDES |
WO2022204430A1 (en) * | 2021-03-24 | 2022-09-29 | Atalanta Therapeutics, Inc. | Double-stranded sirna having patterned chemical modifications |
JP2024521907A (ja) * | 2021-06-04 | 2024-06-04 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | ヒト9番染色体オープンリーディングフレーム72(C9ORF72)iRNA剤組成物及びその使用方法 |
US20230193281A1 (en) * | 2021-11-08 | 2023-06-22 | University Of Massachusetts | Oligonucleotides for sod1 modulation |
US20230348907A1 (en) * | 2022-01-10 | 2023-11-02 | University Of Massachusetts | Oligonucleotides for mecp2 modulation |
WO2024036186A2 (en) * | 2022-08-09 | 2024-02-15 | The University Of Massachusetts | Identification of allele-specific target sequences for c9orf72 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090176725A1 (en) * | 2005-08-17 | 2009-07-09 | Sirna Therapeutics Inc. | Chemically modified short interfering nucleic acid molecules that mediate rna interference |
JP6570447B2 (ja) * | 2012-10-15 | 2019-09-04 | アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. | C9orf72発現を調節するための組成物 |
CN105637090B (zh) * | 2013-10-11 | 2020-10-16 | Ionis制药公司 | 用于调节c9orf72表达的组合物 |
CA2978103A1 (en) * | 2015-04-16 | 2016-10-20 | Ionis Pharmaceuticals, Inc. | Compositions for modulating c9orf72 expression |
WO2017109757A1 (en) * | 2015-12-23 | 2017-06-29 | Crispr Therapeutics Ag | Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration |
CA3011894A1 (en) * | 2016-01-31 | 2017-08-03 | University Of Massachusetts | Branched oligonucleotides |
IL307726A (en) * | 2017-02-06 | 2023-12-01 | Mpeg La Llc | Multimeric oligonucleotides with reduced renal clearance |
EP3630199A4 (en) * | 2017-06-02 | 2021-11-10 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THEIR USE |
WO2019094694A1 (en) * | 2017-11-10 | 2019-05-16 | University Of Massachusetts | Compositions and methods for the treatment of expanded repeat-associated disorders |
CN115151641A (zh) * | 2019-12-13 | 2022-10-04 | 阿尔尼拉姆医药品有限公司 | 人类染色体9开放阅读框72(C9ORF72)iRNA剂组合物及其使用方法 |
-
2020
- 2020-03-27 WO PCT/US2020/025432 patent/WO2020205605A2/en active Search and Examination
- 2020-03-27 EP EP20782396.4A patent/EP3946374A4/en active Pending
- 2020-03-27 AU AU2020252020A patent/AU2020252020A1/en active Pending
- 2020-03-27 JP JP2021557938A patent/JP2022528487A/ja active Pending
- 2020-03-27 CA CA3133784A patent/CA3133784A1/en active Pending
- 2020-03-27 US US16/833,107 patent/US20200385737A1/en active Pending
-
2023
- 2023-06-09 US US18/332,415 patent/US20240132892A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10538763B2 (en) | Compounds and methods for modulation of DUX4 | |
JP2021011501A (ja) | キメラ2重鎖核酸 | |
US11260073B2 (en) | Compounds and methods for modulating C90RF72 | |
AU2014259953B2 (en) | Compounds and methods for enhanced cellular uptake | |
JP2018516091A5 (ru) | ||
WO2020061177A1 (en) | Rnai agents for inhibiting expression of 17beta-hsd type 13- (hsd17b13), compositions thereof, and methods of use | |
AU2010258875A1 (en) | Chemical modification motifs for miRNA inhibitors and mimetics | |
JP2024056820A (ja) | Scn9a発現を調節するためのオリゴヌクレオチド | |
CA3109133A1 (en) | Modified oligonucleotides targeting snps | |
US20210315918A1 (en) | Compounds and Methods for Modulation of Transcript Processing | |
JPWO2019022196A1 (ja) | 一本鎖オリゴヌクレオチド | |
JP6882735B2 (ja) | 構造強化されたmiRNA阻害剤S−TuD | |
JPWO2020205605A5 (ru) | ||
CA3149835A1 (en) | Chemically modified oligonucleotides targeting snps | |
JPWO2020033899A5 (ru) | ||
WO2021157730A1 (ja) | 核酸医薬とその使用 | |
JPWO2020190768A5 (ru) | ||
JPWO2021216556A5 (ru) | ||
JPWO2021188626A5 (ru) | ||
JPWO2021119226A5 (ru) | ||
JPWO2021188661A5 (ru) | ||
WO2022250050A1 (ja) | scpBNA又はAmNAを含むヘテロ核酸 | |
Winkler | Therapeutic strategies for modulating epigenetic mechanisms in cardiovascular disease | |
WO2023081823A1 (en) | Lipid conjugation for targeting astrocytes of the central nervous system | |
WO2023081822A1 (en) | Lipid conjugation for targeting oligodendrocytes of the central nervous system |